PUBLISHER: The Business Research Company | PRODUCT CODE: 1946573
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946573
Myopia treatment devices are a range of tools and technologies designed to manage or correct myopia (nearsightedness). These devices employ advanced techniques, such as reshaping the cornea with ortho-K lenses or using atropine drops, to slow myopia progression and improve vision without the need for continuous corrective eyewear.
The main types of myopia treatment devices include eyeglasses, contact lenses, ortho-K lenses, phakic intraocular lenses, and excimer laser refractive surgery devices. Eyeglasses are wearable optical devices created to correct vision issues or protect the eyes. Treatment options include corrective lenses, laser eye surgery, and lens implant surgery, with end users including hospitals, clinics, ophthalmic centers, retail stores, and online platforms.
Tariffs are impacting the myopia treatment devices market by increasing costs of imported optical components, lenses, and laser system parts. Advanced devices such as excimer lasers and ortho-k lenses are most impacted, particularly in North America and Europe. Despite cost pressures, tariffs have encouraged regional manufacturing, localized lens production, and technological innovation in cost-efficient vision correction devices.
The myopia treatment devices market research report is one of a series of new reports from The Business Research Company that provides myopia treatment devices market statistics, including myopia treatment devices industry global market size, regional shares, competitors with a myopia treatment devices market share, detailed myopia treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the myopia treatment devices industry. This myopia treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The myopia treatment devices market size has grown strongly in recent years. It will grow from $7.48 billion in 2025 to $8.17 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to rising screen exposure, increasing pediatric myopia rates, growing eyewear adoption, urban lifestyle changes, awareness of vision correction.
The myopia treatment devices market size is expected to see strong growth in the next few years. It will grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to AI-based eye diagnostics, expansion of ortho-k adoption, growth of laser vision correction, preventive pediatric eye care demand, personalized ophthalmic solutions. Major trends in the forecast period include myopia control lenses, early childhood vision correction, non-surgical vision management, customized vision therapy, minimally invasive laser treatments.
The growing prevalence of eye diseases is expected to drive the expansion of the myopia treatment devices market. Eye diseases encompass a wide range of conditions that affect the eye's structure or function, potentially leading to vision impairment. The rise in these diseases can be attributed to factors such as aging populations, increased screen time, lifestyle changes, and heightened exposure to environmental pollutants. Myopia treatment devices assist in managing these conditions by slowing myopia progression, enhancing visual clarity, and reducing the risk of complications, offering a proactive approach to maintaining eye health and improving the quality of life for those affected. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that 17.2% of Americans aged 40 and above, approximately 20.5 million individuals, will have cataracts in at least one eye, with this figure projected to exceed 30 million by 2028. This increasing incidence of eye diseases is driving the growth of the myopia treatment devices market.
Major companies operating in the myopia treatment devices market are increasingly focusing on innovation and technological advancements, such as cloud-based orthokeratology platforms, to enhance their competitive positioning and address the rising demand for effective myopia management solutions. Orthokeratology lenses are specially engineered overnight lenses that temporarily reshape the cornea to correct myopia, eliminating the need for daytime corrective eyewear. For example, in March 2025, Bausch + Lomb Corporation, a Canada-based eye health company, introduced Arise, a new orthokeratology lens system in the United States that leverages cloud-based intelligent design tools to enable faster and more accurate lens fitting. The Arise system features FDA-cleared shaping lenses designed for overnight myopia reduction, safely reshaping the cornea while the patient sleeps. This advancement is intended to improve fitting efficiency for eye-care professionals, reduce chair time, and support clinicians in more effectively managing pediatric myopia. Additionally, the system offers real-time data insights and design recommendations, allowing for more precise customization for young patients and improved treatment outcomes.
In January 2023, CooperVision Inc., a US-based contact lens manufacturer, acquired SynergEyes Inc. for an undisclosed amount. This acquisition allows CooperVision to expand its specialty contact lens portfolio, particularly by incorporating SynergEyes' hybrid lens technologies, which are used in the treatment of keratoconus and irregular corneas. SynergEyes is a US-based developer specializing in hybrid contact lenses, including those for myopia treatment.
Major companies operating in the myopia treatment devices market are EssilorLuxottica S.A., Carl Zeiss Meditec AG, Alcon Inc., Hoya Corporation, Bausch & Lomb Incorporated, CooperVision Inc., Johnson & Johnson Vision Care Inc., Topcon Corporation, Menicon Co. Ltd., STAAR Surgical Company, Paragon Vision Sciences Inc., Ziemer Ophthalmic Systems AG, Euclid Systems Corporation, Art Optical Contact Lens Inc., Schwind Eye Tech Solutions GmbH, Kubota Pharmaceutical Holdings Co Ltd., Visioneering Technologies Inc., Eyerising International, Nidek Co Ltd., Falco Linsen AG
North America was the largest region in the myopia treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the myopia treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The myopia treatment devices market consists of sales of orthokeratology (ortho-k) lenses, myopia control contact lenses, atropine eye drops, smart glasses, and peripheral defocus lenses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Myopia Treatment Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses myopia treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for myopia treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The myopia treatment devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.